We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · June 13, 2020

Anti-EGFR Effective in MSI Metastatic Colorectal Cancer of Familial but Not Sporadic Origin

Journal of the National Cancer Institute

 

Additional Info

Journal of the National Cancer Institute
Efficacy of Anti-EGFR in MSI Metastatic Colorectal Cancer Depending on Sporadic or Familial Origin
J. Natl. Cancer Inst 2020 May 16;[EPub Ahead of Print], A Zaanan, J Henriques, R Cohen, D Sefrioui, C Evrard, C de la Fouchardiere, T Lecomte, T Aparicio, M Svrcek, J Taieb, T André, D Vernerey, D Tougeron

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading